MCM
AIDX

MAI Capital Management’s 20/20 Biolabs Inc AIDX Stock Holding History

MAI Capital Management’s Portfolio AIDX Stock Details AIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.88K Buy
+1,000
New +$4.22K ﹤0.01% 3951

Other funds holding AIDX

CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

MAI Capital Management's AIDX Position: Q1 2026 in Review

MAI Capital Management opened a new position in 20/20 Biolabs Inc (AIDX) in Q1 2026: 1,000 shares worth $1.88K. The stake represents ﹤0.01% of the portfolio and ranks #3951 among its holdings.

7 funds tracked by Wall St. Rank hold AIDX as of Q1 2026.

  • MAI Capital Management held 1,000 shares of 20/20 Biolabs Inc worth $1.88K as of Q1 2026.
  • 20/20 Biolabs Inc was a new MAI Capital Management position in Q1 2026.
  • 20/20 Biolabs Inc made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #3951 holding.
  • 7 funds tracked by Wall St. Rank held 20/20 Biolabs Inc as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.